Kathleen McElhone - Concepedia

Author

Kathleen McElhone

Also Known As

Ian Evans, K McElhone, K Mcelhone, K. MCelhone, K. McELHONE, K. McElhone, K. Mcelhone, KATHLEEN McELHONE, Kathleen McElhone, Kathleen Mcelhone

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

University of Manchester Manchester Academic Health Science Centre Salford Royal NHS Foundation Trust Guy's and St Thomas' NHS Foundation Trust Royal Victoria Infirmary

About

Kathleen McElhone is an author at University of Manchester specializing in medicine, dermatology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	586
2	Immunology	2	2	174
3	Autoimmune Disease	2	2	174
4	Autoimmunity	2	2	174
5	Pathology	1	1	12

Kathleen McElhone

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR) Richard B. Warren, Catherine Smith, Zenas Z N Yiu, Journal of Investigative Dermatology British AssociationClinical EpidemiologyClinical DermatologySkin PharmacologyPharmacotherapy	2015	366
Development and validation of a disease‐specific health‐related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus Kathleen McElhone, Janice Abbott, J. Shelmerdine, Arthritis Care & Research	2007	330
Psychological Distress Impairs Clearance of Psoriasis in Patients Treated With Photochemotherapy Dónal G. Fortune, Helen L. Richards, Brian Kirby, Archives of Dermatology	2003	243
HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis Nick Dand, Michael Duckworth, David Baudry, Journal of Allergy and Clinical Immunology Autoimmune DiseaseMedicineBiologic Treatment ResponseImmunologyClinical Dermatology	2018	162
Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative study Kathleen McElhone, Janice Abbott, Julie McLaughlin Gray, Lupus	2010	122
Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled study M. Bhushan, A. David Burden, Kathleen McElhone, British Journal of Dermatology	2001	120
The British Association of Dermatologists’ Biologic Interventions Register (BADBIR): design, methodology and objectives A. David Burden, Richard B. Warren, C. Elise Kleyn, British Journal of Dermatology	2012	119
Demographics and disease characteristics of patients with psoriasis enrolled in the<scp>B</scp>ritish<scp>A</scp>ssociation of<scp>D</scp>ermatologists<scp>B</scp>iologic<scp>I</scp>nterventions<scp>R</scp>egister Ireny Iskandar, Darren M. Ashcroft, Richard B. Warren, British Journal of Dermatology	2015	106
Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR K.J. Mason, Juliet N. Barker, Catherine Smith, JAMA Dermatology	2018	100
Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR) Ireny Iskandar, Richard B. Warren, Mark Lunt, Journal of Investigative Dermatology	2017	95

Page 1